Metoject subcutaneous injection 10mg pen 0.20mL

Metoject subcutaneous injection 10mg pen 0.20mL, manufactured by Japan Medac, contains methotrexate. Methotrexate is an antimetabolite and immunosuppressant indicated for various cancers, autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, and severe psoriasis. It works by inhibiting enzymes involved in nucleotide synthesis and modulating immune function. It is supplied as a 10mg/0.2mL/1 kit injectable drug (YJ code: 3999468G6020).